Alphagan P ALPHAGAN P - Prescribing Info PDF
Font SizeSize 1Size 2Size 3right
Get Adobe Acrobat Reader
Complex Patients
 

Coexisting Conditions

Treating glaucoma patients is complicated by the following medical conditions1:
Most Common Systemic Disorders
 
Indication: ALPHAGAN® P 0.1% ophthalmic solution is indicated for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Important Safety Information
Contraindication: ALPHAGAN® P 0.1% is contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy.
Precautions: Although ALPHAGAN® P 0.1% ophthalmic solution had minimal effect on the blood pressure of patients in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease. ALPHAGAN® P 0.1% should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangiitis obliterans.
Adverse reactions: Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, conjunctival hyperemia, and eye pruritus.

Please click here for full prescribing information.

1. Gottfredsdottir MS, Allingham RR, Shields MB. Physicians' guide to interactions between glaucoma and systemic medications. J Glaucoma. 1997;6(6):377-383.